You neglect the USD$ milestone millions that will come before the first royalty payment but yes it will take 2 years for Ipix to receive USD$50 million from Alfasigma for this small rectum use of Brilacidin.
I'd like to see that math and timeline. B-UP cannot be approved within 2 years let alone hit any sales milestones. One year to finish phase 2 and get phase 3 approval. One year to do phase 3. One year for NDA to be approved and production ramped before sales. That's pretty aggressive.
ut I do not think Ipix will need to pay a Brilacidin Phase 3 trial within the next 2 years with only their own money. I think their new partners will pay for most. I think the next Phase 3 that Ipix pays alone is maybe Kevetrin. That will cost USD$150 million or more but is a super good investment.
I eagerly await these partners. I do hope they show up soon. Been waiting six years already for B-ABSSSI. Four years since our B-OM phase 2 trial finished.
President and Chairman of the IPIX Bagholder's Club. Don't listen to me...I've been buying IPIX since 2015.